204 related articles for article (PubMed ID: 27556957)
1. The impact of sentinel node dissection on disease-free and overall tumour-specific survival in melanoma patients: a single centre group-matched analysis of 1192 patients.
Geimer T; Sattler EC; Flaig MJ; Ruzicka T; Berking C; Schmid-Wendtner MH; Kunte C
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):629-635. PubMed ID: 27556957
[TBL] [Abstract][Full Text] [Related]
2. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.
Leiter U; Stadler R; Mauch C; Hohenberger W; Brockmeyer N; Berking C; Sunderkötter C; Kaatz M; Schulte KW; Lehmann P; Vogt T; Ulrich J; Herbst R; Gehring W; Simon JC; Keim U; Martus P; Garbe C;
Lancet Oncol; 2016 Jun; 17(6):757-767. PubMed ID: 27161539
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma.
Kang JC; Wanek LA; Essner R; Faries MB; Foshag LJ; Morton DL
J Clin Oncol; 2005 Jul; 23(21):4764-70. PubMed ID: 16034052
[TBL] [Abstract][Full Text] [Related]
4. Lymph node status and survival in cutaneous malignant melanoma--sentinel lymph node biopsy impact.
Rutkowski P; Nowecki ZI; Nasierowska-Guttmejer A; Ruka W
Eur J Surg Oncol; 2003 Sep; 29(7):611-8. PubMed ID: 12943629
[TBL] [Abstract][Full Text] [Related]
5. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement.
Leiter U; Buettner PG; Bohnenberger K; Eigentler T; Meier F; Moehrle M; Breuninger H; Garbe C
Ann Surg Oncol; 2010 Jan; 17(1):129-37. PubMed ID: 19866238
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
[TBL] [Abstract][Full Text] [Related]
8. Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institution.
van der Ploeg AP; Haydu LE; Spillane AJ; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Uren RF; Scolyer RA; Thompson JF
Ann Surg; 2014 Jul; 260(1):149-57. PubMed ID: 24633018
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of sentinel lymph node dissection for melanoma staging in the presence of a collision tumour with a lymphoproliferative disease.
Gero D; Queiros da Mota V; Boubaker A; Berthod G; de Leval L; Demartines N; Matter M
Melanoma Res; 2014 Aug; 24(4):371-6. PubMed ID: 24922190
[TBL] [Abstract][Full Text] [Related]
10. Role of elective lymph node dissection in stage I malignant melanoma: evaluation by matched pair analysis.
Rompel R; Garbe C; Büttner P; Teichelmann K; Petres J
Recent Results Cancer Res; 1995; 139():323-36. PubMed ID: 7597301
[TBL] [Abstract][Full Text] [Related]
11. Sentinel Lymph Node Dissection in Head and Neck Melanoma has Prognostic Impact on Disease-Free and Overall Survival.
Leiter U; Eigentler TK; Häfner HM; Krimmel M; Uslu U; Keim U; Weide B; Breuninger H; Martus P; Garbe C
Ann Surg Oncol; 2015 Nov; 22(12):4073-80. PubMed ID: 25712801
[TBL] [Abstract][Full Text] [Related]
12. Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection.
Clary BM; Mann B; Brady MS; Lewis JJ; Coit DG
Ann Surg Oncol; 2001 May; 8(4):328-37. PubMed ID: 11352306
[TBL] [Abstract][Full Text] [Related]
13. Benefit of sentinel lymphadenectomy for patients with nonulcerated cutaneous melanomas in the Breslow range between 0.76 and 1 mm: a follow-up study of 148 patients.
Starz H; Balda BR
Int J Cancer; 2007 Aug; 121(3):689-93. PubMed ID: 17397029
[TBL] [Abstract][Full Text] [Related]
14. Primary Dermal Melanoma (PDM): Histological and Clinical Interdependence to Guide Therapy.
Zamir H; Feinmesser M; Gutman H
J Cutan Med Surg; 2021; 25(1):53-58. PubMed ID: 32912013
[TBL] [Abstract][Full Text] [Related]
15. Sentinel-node biopsy or nodal observation in melanoma.
Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
[TBL] [Abstract][Full Text] [Related]
16. Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 Study.
Klapdor R; Hillemanns P; Wölber L; Jückstock J; Hilpert F; de Gregorio N; Iborra S; Sehouli J; Habermann A; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Meier W; Harter P; Wimberger P; Hanker L; Schmalfeldt B; Canzler U; Fehm T; Luyten A; Hellriegel M; Kosse J; Heiss C; Hantschmann P; Mallmann P; Tanner B; Pfisterer J; Richter B; Jäger M; Mahner S
Ann Surg Oncol; 2017 May; 24(5):1314-1321. PubMed ID: 27896515
[TBL] [Abstract][Full Text] [Related]
17. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
[TBL] [Abstract][Full Text] [Related]
18. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.
Faries MB; Thompson JF; Cochran AJ; Andtbacka RH; Mozzillo N; Zager JS; Jahkola T; Bowles TL; Testori A; Beitsch PD; Hoekstra HJ; Moncrieff M; Ingvar C; Wouters MWJM; Sabel MS; Levine EA; Agnese D; Henderson M; Dummer R; Rossi CR; Neves RI; Trocha SD; Wright F; Byrd DR; Matter M; Hsueh E; MacKenzie-Ross A; Johnson DB; Terheyden P; Berger AC; Huston TL; Wayne JD; Smithers BM; Neuman HB; Schneebaum S; Gershenwald JE; Ariyan CE; Desai DC; Jacobs L; McMasters KM; Gesierich A; Hersey P; Bines SD; Kane JM; Barth RJ; McKinnon G; Farma JM; Schultz E; Vidal-Sicart S; Hoefer RA; Lewis JM; Scheri R; Kelley MC; Nieweg OE; Noyes RD; Hoon DSB; Wang HJ; Elashoff DA; Elashoff RM
N Engl J Med; 2017 Jun; 376(23):2211-2222. PubMed ID: 28591523
[TBL] [Abstract][Full Text] [Related]
19. Clinical Prognostic Markers in Stage IIIB Melanoma.
Madu MF; Wouters MW; Klop WM; van der Hiel B; van de Wiel BA; Jóźwiak K; van der Hage JA; van Akkooi AC
Ann Surg Oncol; 2016 Dec; 23(13):4195-4202. PubMed ID: 27380642
[TBL] [Abstract][Full Text] [Related]
20. Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node.
Leiter U; Stadler R; Mauch C; Hohenberger W; Brockmeyer NH; Berking C; Sunderkötter C; Kaatz M; Schatton K; Lehmann P; Vogt T; Ulrich J; Herbst R; Gehring W; Simon JC; Keim U; Verver D; Martus P; Garbe C;
J Clin Oncol; 2019 Nov; 37(32):3000-3008. PubMed ID: 31557067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]